The Discounted Cash Flow (DCF) valuation of Sapporo Clinical Laboratory Inc (9776.T) is 1,559.30 JPY. With the latest stock price at 998.00 JPY, the upside of Sapporo Clinical Laboratory Inc based on DCF is 56.2%.
Based on the latest price of 998.00 JPY and our DCF valuation, Sapporo Clinical Laboratory Inc (9776.T) is a buy. buying 9776.T stocks now will result in a potential gain of 56.2%.
Range | Selected | |
WACC / Discount Rate | 4.4% - 7.0% | 5.7% |
Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
Fair Price | 1,207.79 - 2,275.06 | 1,559.30 |
Upside | 21.0% - 128.0% | 56.2% |